SG11201500187WA - Methods of manufacturing cartilage products - Google Patents

Methods of manufacturing cartilage products

Info

Publication number
SG11201500187WA
SG11201500187WA SG11201500187WA SG11201500187WA SG11201500187WA SG 11201500187W A SG11201500187W A SG 11201500187WA SG 11201500187W A SG11201500187W A SG 11201500187WA SG 11201500187W A SG11201500187W A SG 11201500187WA SG 11201500187W A SG11201500187W A SG 11201500187WA
Authority
SG
Singapore
Prior art keywords
methods
cartilage products
manufacturing cartilage
manufacturing
products
Prior art date
Application number
SG11201500187WA
Other languages
English (en)
Inventor
Dana Sue Yoo
Jin-Qiang Kuang
Jaime Paden
Scott A Maxson
Alla Danilkovitch
Erasmo Lopez
Samson Tom
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of SG11201500187WA publication Critical patent/SG11201500187WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3612—Cartilage, synovial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A61L27/3654—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201500187WA 2012-07-11 2013-07-11 Methods of manufacturing cartilage products SG11201500187WA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261670444P 2012-07-11 2012-07-11
US201261670424P 2012-07-11 2012-07-11
US201261670434P 2012-07-11 2012-07-11
PCT/US2013/050094 WO2014011891A1 (fr) 2012-07-11 2013-07-11 Procédés de fabrication de produits de cartilage

Publications (1)

Publication Number Publication Date
SG11201500187WA true SG11201500187WA (en) 2015-03-30

Family

ID=49914172

Family Applications (3)

Application Number Title Priority Date Filing Date
SG11201500187WA SG11201500187WA (en) 2012-07-11 2013-07-11 Methods of manufacturing cartilage products
SG11201500181UA SG11201500181UA (en) 2012-07-11 2013-07-11 Disrupted cartilage products
SG11201500189PA SG11201500189PA (en) 2012-07-11 2013-07-11 Porated cartilage products

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG11201500181UA SG11201500181UA (en) 2012-07-11 2013-07-11 Disrupted cartilage products
SG11201500189PA SG11201500189PA (en) 2012-07-11 2013-07-11 Porated cartilage products

Country Status (10)

Country Link
US (8) US20140030309A1 (fr)
EP (3) EP2872071A4 (fr)
JP (3) JP2015523154A (fr)
KR (3) KR20150048115A (fr)
AU (3) AU2013290152B2 (fr)
BR (3) BR112015000670A2 (fr)
CA (3) CA2878808A1 (fr)
MX (3) MX2015000463A (fr)
SG (3) SG11201500187WA (fr)
WO (3) WO2014011889A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
CA2878808A1 (fr) * 2012-07-11 2014-01-16 Osiris Therapeutics, Inc. Procedes de fabrication de produits de cartilage
EP2919794B1 (fr) 2012-11-15 2021-01-20 AlloSource Systèmes de cartilage haché et méthodes associées
WO2014130883A2 (fr) 2013-02-22 2014-08-28 Allosource Compositions de mosaïque de cartilage et procédés afférents
KR102138399B1 (ko) 2013-03-15 2020-07-27 알로소스 천공된 골연골 동종이식 조성물
WO2014150784A1 (fr) 2013-03-15 2014-09-25 Allosource Matrice de collagène repeuplée de cellules pour réparation et régénération des tissus mous
US9345589B2 (en) * 2013-12-19 2016-05-24 Ilion Medical, Inc. Bone implants for orthopedic procedures and corresponding methods
AU2015229405B2 (en) 2014-03-11 2019-10-31 The Trustees Of Columbia University In The City Of New York Customized bendable osteochondral allografts
WO2015188020A1 (fr) * 2014-06-06 2015-12-10 Vivoscript, Inc. Méthode de réparation de lésion cartilagineuse
EP3193953B1 (fr) 2014-09-19 2020-03-11 Osiris Therapeutics, Inc. Produit de réparation osseuse et ses procédés d'utilisation
EP3202772B1 (fr) * 2014-09-30 2020-10-28 Jiangsu Hengrui Medicine Co. Ltd. Cristal du complexe l-proline/inhibiteur du cotransporteur sodium-glucose de type 2
US10524774B2 (en) 2015-04-02 2020-01-07 Arthrex, Inc. Method of repairing cartilage defects
CA2984450A1 (fr) * 2015-04-27 2016-11-03 Donald Steven Corenman Greffe de disque biologique et procede permettant de soulager douleur lombaire et douleur articulaire
US10524775B2 (en) 2015-07-02 2020-01-07 Arthrex, Inc. Methods of repairing cartilage defects
US10407669B2 (en) * 2015-07-28 2019-09-10 Global Bioenergies HIV kinase variants
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US10425377B2 (en) * 2015-12-09 2019-09-24 Facebook, Inc. Systems and methods to manage an event broadcast in a social network
US10498674B2 (en) * 2016-06-21 2019-12-03 Oracle International Corporation Internet cloud-hosted natural language interactive messaging system sessionizer
CN106244529B (zh) * 2016-09-28 2019-10-25 广州赛莱拉干细胞科技股份有限公司 一种快速高效分离软骨细胞的方法
US11121946B2 (en) * 2016-12-09 2021-09-14 Nicira, Inc. Capturing packets in a virtual switch
AU2018234923A1 (en) * 2017-03-17 2019-10-17 The Scripps Research Institute Functionalized scaffold to promote meniscus repair
EP3630213B1 (fr) * 2017-05-30 2023-07-05 Trauma Care Consult Traumatologische Forschung Gemeinnützige Gesellschaft mbH Échafaudage cartilaginoïde décellularisé
EP3470096A1 (fr) * 2017-10-13 2019-04-17 Erasmus University Medical Center Rotterdam Réduction d'élastine permettant la recellularisation d'implants de cartilage
CN112295015A (zh) * 2020-02-10 2021-02-02 中国人民解放军第二军医大学 一种修复软骨缺损的生物3d打印复合墨水的制备方法
WO2022203220A1 (fr) * 2021-03-26 2022-09-29 에이템즈 주식회사 Procédé de cryoconservation et de décongélation de tissu cartilagineux
CN115737930A (zh) * 2022-11-28 2023-03-07 江苏省人民医院（南京医科大学第一附属医院） 一种全层多孔骨软骨组织工程支架及其制备方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306311A (en) * 1987-07-20 1994-04-26 Regen Corporation Prosthetic articular cartilage
US5131850A (en) * 1989-11-03 1992-07-21 Cryolife, Inc. Method for cryopreserving musculoskeletal tissues
US5853746A (en) * 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5326357A (en) * 1992-03-18 1994-07-05 Mount Sinai Hospital Corporation Reconstituted cartridge tissue
US6080194A (en) 1995-02-10 2000-06-27 The Hospital For Joint Disease Orthopaedic Institute Multi-stage collagen-based template or implant for use in the repair of cartilage lesions
US7141072B2 (en) 1998-10-05 2006-11-28 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method for promoting regeneration of surface cartilage in a damaged joint using multi-layer covering
GB9721585D0 (en) * 1997-10-10 1997-12-10 Geistlich Soehne Ag Chemical product
GB9503492D0 (en) 1995-02-22 1995-04-12 Ed Geistlich S Hne A G F R Che Chemical product
US6049025A (en) 1995-09-15 2000-04-11 Stone; Kevin R. Articular cartilage xenografts
US6569172B2 (en) 1996-08-30 2003-05-27 Verigen Transplantation Service International (Vtsi) Method, instruments, and kit for autologous transplantation
US20020173806A1 (en) 1996-08-30 2002-11-21 Verigen Transplantation Service International (Vtsi) Ag Method for autologous transplantation
GB9704749D0 (en) * 1997-03-07 1997-04-23 Univ London Tissue Implant
EP1018987B1 (fr) 1997-04-04 2014-10-29 Barnes-Jewish Hospital Neocartilage et ses methodes d'utilisation
EP0896825B1 (fr) 1997-08-14 2002-07-17 Sulzer Innotec Ag Composition et dispositif pour la réparation de cartilage in vivo comprenant des nanocapsules avec des facteurs ostéoinductifs et/ou chondroinductifs
EP1059891A4 (fr) * 1998-03-06 2004-05-19 Crosscart Inc Xenogreffes de tissus mous
US20080077251A1 (en) * 1999-06-07 2008-03-27 Chen Silvia S Cleaning and devitalization of cartilage
US6132468A (en) * 1998-09-10 2000-10-17 Mansmann; Kevin A. Arthroscopic replacement of cartilage using flexible inflatable envelopes
US6530956B1 (en) * 1998-09-10 2003-03-11 Kevin A. Mansmann Resorbable scaffolds to promote cartilage regeneration
US6197061B1 (en) 1999-03-01 2001-03-06 Koichi Masuda In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage
US6194137B1 (en) 1999-04-13 2001-02-27 Organ Recovery Systems, Inc. Method of cryopreservation of blood vessels by vitrification
EP1441028A3 (fr) 1999-07-28 2005-01-05 Interface Biotech A/S Procédé de culture cellulaire pour la préparation de chondrocytes/chondroblastes
US6773713B2 (en) * 2001-02-23 2004-08-10 University Of Massachusetts Injection molding of living tissues
MXPA03009312A (es) * 2001-04-12 2004-03-10 Verigen Transplantation Serv Metodo para trasplante autologo.
EP1254670A1 (fr) * 2001-05-03 2002-11-06 Stichting Katholieke Universiteit Matrices de collagène II pour la régéneration de cartilage
AU2002335747B2 (en) * 2001-09-15 2009-01-29 Rush University Medical Center Stratified cartilage tissue and methods to engineer same
CA2412012C (fr) 2001-11-20 2011-08-02 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Matrice extracellulaire resorbable contenant du collagene i et du collagene ii pour la reconstruction de cartilage
CA2483660A1 (fr) 2002-05-01 2003-11-13 Verigen Ag Implant injectable comprenant des chondrocytes
US7931687B2 (en) 2002-05-13 2011-04-26 Articular Engineering, Llc Tissue engineered osteochondral implant
US7594934B2 (en) 2002-06-14 2009-09-29 Crosscart, Inc. Galactosidase-treated prosthetic devices
US7498040B2 (en) 2005-10-12 2009-03-03 Lifenet Health Compositions for repair of defects in osseous tissues, and methods of making the same
WO2004067704A2 (fr) 2003-01-30 2004-08-12 Prochon Biotech Ltd. Matrices de fibrine lyophilisees et leurs procedes de preparation
US8173162B2 (en) 2003-02-26 2012-05-08 Zimmer Orthobiologics, Inc. Preparation for repairing cartilage tissue, especially articular cartilage defects
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20070077237A1 (en) 2003-10-09 2007-04-05 Udi Damari Method for freezing, thawing and transplantation of viable cartilage
DE20315960U1 (de) 2003-10-13 2004-02-12 Aesculap Ag & Co. Kg Knorpelersatzimplantat
ES2403357T3 (es) 2003-12-11 2013-05-17 Isto Technologies Inc. Sistema de cartílago particulado
EP1701729B1 (fr) * 2003-12-31 2018-05-02 Warsaw Orthopedic, Inc. Compositions de matrice osseuse ameliorees et methodes associees
US20060275273A1 (en) * 2004-02-20 2006-12-07 Seyedin Mitchell S Intervertebral Disc Repair, Methods and Devices Therefor
WO2005105992A1 (fr) * 2004-04-21 2005-11-10 New York Eye & Ear Infirmary Formulations de culture de chondrocytes
US20090104093A1 (en) 2004-08-23 2009-04-23 Reckitt Benckiser N.V. Detergent dispensing device
EP1850661A2 (fr) 2005-02-22 2007-11-07 Interface Multigrad Technology (IMT) Ltd. Cartilage viable conserve, son procede de conservation, et systeme et dispositifs de mise en oeuvre
US20070038299A1 (en) * 2005-08-12 2007-02-15 Arthrotek, Inc Multilayer microperforated implant
AU2006292224B2 (en) * 2005-09-19 2013-08-01 Histogenics Corporation Cell-support matrix and a method for preparation thereof
EP1764117A1 (fr) * 2005-09-20 2007-03-21 Zimmer GmbH Implant pour la réparation de défauts cartilagineux et son procédé de préparation
KR20080075494A (ko) * 2005-09-21 2008-08-18 다스크 테크날러지, 엘엘씨 장기 및 조직 기능성을 위한 방법 및 조성물
JP2009516544A (ja) * 2005-11-18 2009-04-23 セラマテック・インク 多孔性耐力セラミックス又は金属インプラント
US8728387B2 (en) 2005-12-06 2014-05-20 Howmedica Osteonics Corp. Laser-produced porous surface
US20070250164A1 (en) * 2006-04-21 2007-10-25 Biomet Manufacturing Corp. Method for grafting whole superficial articular cartilage
US20070299517A1 (en) 2006-06-21 2007-12-27 Howmedica Osteonics Corp. Articular cartilage implant
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
US9125743B2 (en) * 2007-07-16 2015-09-08 Lifenet Health Devitalization and recellularization of cartilage
US20090024224A1 (en) 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
DK2274023T3 (da) 2008-04-10 2020-03-16 Bonus Therapeutics Ltd Knoglelignende proteseimplantater
US20100274362A1 (en) * 2009-01-15 2010-10-28 Avner Yayon Cartilage particle tissue mixtures optionally combined with a cancellous construct
DE102009018640A1 (de) 2009-04-17 2010-10-21 Tetec Tissue Engineering Technologies Ag Implantat und therapeutische Zusammensetzung zur Behandlung von Schäden und/oder Erkrankungen im Bereich des menschlichen und/oder tierischen Stütz- und Bewegungsapparates
US20130084636A1 (en) 2010-02-24 2013-04-04 Te Bios Co., Ltd Scaffold for articular cartilage regeneration and method for manufacturing same
CN102526806B (zh) 2012-01-20 2013-12-18 陕西博鸿生物科技有限公司 一种组织工程软骨及其制备方法
CA2878808A1 (fr) * 2012-07-11 2014-01-16 Osiris Therapeutics, Inc. Procedes de fabrication de produits de cartilage
DK2878808T3 (en) 2013-12-02 2017-10-02 Moog Unna Gmbh PITCH SYSTEM AND PROCEDURE FOR OPERATING A PITCH SYSTEM IN A WINDOW ENERGY INSTALLATION

Also Published As

Publication number Publication date
SG11201500189PA (en) 2015-03-30
JP2015523154A (ja) 2015-08-13
US20140017292A1 (en) 2014-01-16
CA2878808A1 (fr) 2014-01-16
EP2874571A1 (fr) 2015-05-27
JP2015523153A (ja) 2015-08-13
EP2872189A4 (fr) 2016-03-16
BR112015000668A2 (pt) 2017-06-27
AU2013290065A1 (en) 2015-02-19
MX2015000463A (es) 2015-08-14
MX2015000460A (es) 2015-07-06
US11413373B2 (en) 2022-08-16
US20150004211A1 (en) 2015-01-01
AU2013290152A1 (en) 2015-02-19
AU2013290152B2 (en) 2016-11-03
US20220331485A1 (en) 2022-10-20
US20220184277A1 (en) 2022-06-16
CA2878802A1 (fr) 2014-01-16
EP2872189A1 (fr) 2015-05-20
WO2014011891A1 (fr) 2014-01-16
EP2872071A1 (fr) 2015-05-20
BR112015000670A2 (pt) 2017-06-27
JP2015523155A (ja) 2015-08-13
US20150140057A1 (en) 2015-05-21
KR20150048115A (ko) 2015-05-06
US20140030309A1 (en) 2014-01-30
WO2014011890A1 (fr) 2014-01-16
US10874763B2 (en) 2020-12-29
SG11201500181UA (en) 2015-03-30
AU2013290064A1 (en) 2015-02-19
KR20150048720A (ko) 2015-05-07
CA2878921A1 (fr) 2014-01-16
US11406735B2 (en) 2022-08-09
BR112015000669A2 (pt) 2017-06-27
EP2872071A4 (fr) 2016-04-20
EP2874571A4 (fr) 2016-03-16
WO2014011889A1 (fr) 2014-01-16
US20140017283A1 (en) 2014-01-16
US20150017222A1 (en) 2015-01-15
KR20150048114A (ko) 2015-05-06
MX2015000458A (es) 2015-08-14

Similar Documents

Publication Publication Date Title
SG11201500187WA (en) Methods of manufacturing cartilage products
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
GB201301173D0 (en) Object production
EP2836221A4 (fr) Procédé d'utilisation de cyclodextrine
EP2913831A4 (fr) Procédé de production d'un aimant en terre rare
ZA201502519B (en) Production of particles
EP2801073A4 (fr) Procédé de caractérisation de matériaux structurés
PL2931937T3 (pl) Sposób wytwarzania układów nanocząstek metali
GB201220155D0 (en) Method of manufacture
ZA201503683B (en) Production of ethanol products
GB2519045B (en) String of absorbent products
GB201201900D0 (en) Product
GB201201904D0 (en) Product
EP2766862A4 (fr) Procédé de gestion de produits
ZA201405975B (en) Product
EP2855401A4 (fr) Production de matériaux composites bn
GB201215942D0 (en) Method of treatent
GB201201908D0 (en) Product
EP2887938A4 (fr) Procédé de préparation de tecovirimat
GB201321600D0 (en) Method of cleaning
GB201202060D0 (en) Novel compounds and methods for their production
GB201219772D0 (en) Method of manufacturing an article
PL390271A1 (pl) Produkcja wyrobów słonecznikowo-karmelowych
GB201221464D0 (en) Novel process and products
GB201221262D0 (en) Product